#gism

Durvalumab (+FLOT) is now FDA ✅ for resectable Gastric & GEJ adenocarcinoma based off #MATTERHORN! We 🗣️ this trial, findings, PDL1, and AEs w/ Yelena Y. Janjigian MD Full 🗣️: ⭐️ ⭐️ Also on “Oncology Brothers” podcast OncoAlert OncUpdates #gism
Oncology Brothers10,118 просмотров • 10 месяцев назад
Больше нет контента для загрузки